Brain Death Confirmation by 18F-FDG PET/CT: A Case Series.

Objectives: Brain death is a state of irreversible loss of brain function in the cortex and brainstem. Diagnosis of brain death is established by clinical assessments of cranial nerves and apnea tests. Different conditions can mimic brain death.

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version.

Diabetes prevalence is on the rise in the Middle East. In countries of the Gulf region-Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates-prevalence rates are among the highest in the world. Further, Egypt now ranks as one of the top 10 countries in the world for high number of people with diabetes.

Dynamic porous coordination polymers built-up from flexible 4,4'-dithiodibenzoate and rigid N-based ligands.

Herein we report the design, synthesis, structural characterisation and functional testing of a series of Cu(ii) coordination polymers containing flexible 4,4'-dithiodibenzoate ligand (4,4'-DTBA), with or without auxiliary N-donor ligands. Reaction of Cu(ii) with 4,4'-DTBA yielded a 1D coordination polymer (1) based on Cu(ii) paddlewheel units connected by 4,4'-DTBA, to form cyclic loop chains with intramolecular voids that exhibit reversible structural transformations upon subsequent solvent exchange in methanol to afford a new, crystalline, permanently-porous structure (1'). However, when the same reaction was run with pyridine, it formed a porous 2D coordination polymer (2).

Sewage Sludge ZnCl-Activated Carbon Intercalated MgFe-LDH Nanocomposites: Insight of the Sorption Mechanism of Improved Removal of Phenol from Water.

: sludge-activated carbon; MgFe layered double hydroxide; nanocomposite materials; phenol aqueous uptake; mechanistic studies; reusability performance.

Mechanisms of action of metformin with special reference to cardiovascular protection.

Management guidelines continue to identify metformin as initial pharmacologic antidiabetic therapy of choice for people with type 2 diabetes without contraindications, despite recent randomized trials that have demonstrated significant improvements in cardiovascular outcomes with newer classes of antidiabetic therapies. The purpose of this review is to summarize the current state of knowledge of metformin's therapeutic actions on blood glucose and cardiovascular clinical evidence and to consider the mechanisms that underlie them. The effects of metformin on glycaemia occur mainly in the liver, but metformin-stimulated glucose disposal by the gut has emerged as an increasingly import site of action of metformin.